Vivasure Medical has closed an $18.3m series C round co-led by Evonik Venture Capital and will use the cash to commercialise its blood vessel closure device.

Chemicals producer Evonik co-led a €16.2m ($18.3m) series C round today for Vivasure Medical, the Ireland-based developer of a bioabsorbable implant technology for blood vessel closure.

Evonik invested through its Evonik Venture Capital unit, co-leading the round with life sciences-focused investment firm LSP, which participated through its LSP Health Economics Fund.

The round also featured venture capital firm Panakès Partners and existing backers including VC fund Fountain Healthcare Partners. Fountain invested in Vivasure’s series A and B rounds, according to…